Document is current

Any future updates will be listed below

Development of a Protocol for Obtaining a Homologous Cell Product of Animal Origin Intended for Preclinical Studies of Antitumor Vaccine CaTeVac

Crossref DOI link: https://doi.org/10.1007/s10517-024-06113-z

Published Online: 2024-06-22

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark